Triple

T4689705
Position Surface form Disambiguated ID Type / Status
Subject ATC E104004 entity
Predicate maintainedBy P86 FINISHED
Object WHO Collaborating Centre for Drug Statistics Methodology
The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
E462928 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: WHO Collaborating Centre for Drug Statistics Methodology | Statement: [ATC, maintainedBy, WHO Collaborating Centre for Drug Statistics Methodology]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: WHO Collaborating Centre for Drug Statistics Methodology
Context triple: [ATC, maintainedBy, WHO Collaborating Centre for Drug Statistics Methodology]
  • A. European Monitoring Centre for Drugs and Drug Addiction
    The European Monitoring Centre for Drugs and Drug Addiction is an EU agency that provides independent, evidence-based analysis on drugs, drug use, and related consequences to support policymaking in Europe.
  • B. World Health Organization Model List of Essential Medicines
    The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
  • C. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
    The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
  • D. STC on Health, Population and Drug Control
    The STC on Health, Population and Drug Control is an African Union specialized technical committee responsible for guiding and coordinating continental policies and programs on public health, population issues, and drug regulation and control.
  • E. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: WHO Collaborating Centre for Drug Statistics Methodology
Triple: [ATC, maintainedBy, WHO Collaborating Centre for Drug Statistics Methodology]
Generated description
The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: WHO Collaborating Centre for Drug Statistics Methodology
Target entity description: The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
  • A. European Monitoring Centre for Drugs and Drug Addiction
    The European Monitoring Centre for Drugs and Drug Addiction is an EU agency that provides independent, evidence-based analysis on drugs, drug use, and related consequences to support policymaking in Europe.
  • B. World Health Organization Model List of Essential Medicines
    The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
  • C. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
    The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
  • D. STC on Health, Population and Drug Control
    The STC on Health, Population and Drug Control is an African Union specialized technical committee responsible for guiding and coordinating continental policies and programs on public health, population issues, and drug regulation and control.
  • E. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd43df91f481908e9add1b617b60ef completed March 20, 2026, 12:55 p.m.
NER Named-entity recognition batch_69bd6399621881909aa8ffb1c27284e9 completed March 20, 2026, 3:11 p.m.
NED1 Entity disambiguation (via context triple) batch_69be03ba56f88190bc9f6da051b5052f completed March 21, 2026, 2:34 a.m.
NEDg Description generation batch_69be077d06988190b3b20b48e4017abb completed March 21, 2026, 2:50 a.m.
NED2 Entity disambiguation (via description) batch_69be084a59e88190b1e0342a529b7b8f completed March 21, 2026, 2:54 a.m.
Created at: March 20, 2026, 1:16 p.m.